Brahm S Srivastava

Microbiology Division, Central Drug Research Institute, CSIR, Lucknow 226001, India.

Publications of Brahm S Srivastava

  • In vivo activity of thiophene-containing trisubstituted methanes against acute and persistent infection of non-tubercular Mycobacterium fortuitum in a murine infection model.

    Authors: Vivek Kr Kashyap, Ravi Kr Gupta, Rahul Shrivastava, Brahm S Srivastava, Ranjana Srivastava, Maloy Kumar Parai, Priyanka Singh, Saurav Bera, Gautam Panda

    The Journal of antimicrobial chemotherapy. 02/2012;

    OBJECTIVES: Mycobacterium fortuitum causes opportunist non-tubercular infection in humans. Chronic infection of M. fortuitum has been clinically documented and requires prolonged chemotherapy. The
  • Functional characterization of VC1929 of Vibrio cholerae El Tor: role in mannose-sensitive haemagglutination, virulence and utilization of sialic acid.

    Authors: Sandeep K Sharma, The Su Moe, Ranjana Srivastava, Deepak Chandra, Brahm S Srivastava

    Microbiology (Reading, England). 08/2011; 157(Pt 11):3180-6.

    The nonadhesive mutant CD11 of Vibrio cholerae El Tor, defective in expression of mannose-sensitive haemagglutinin, lacks a protein when compared with its parent strain. Determination of the amino
  • Overexpression of Rv3097c in Mycobacterium bovis BCG abolished the efficacy of BCG vaccine to protect against Mycobacterium tuberculosis infection in mice.

    Authors: Vipul K Singh, Vikas Srivastava, Vinayak Singh, Neeraj Rastogi, Raja Roy, Arun K Shaw, Anil K Dwivedi, Ranjana Srivastava, Brahm S Srivastava

    Vaccine. 06/2011; 29(29-30):4754-60.

    Rv3097c of Mycobacterium tuberculosis encoding lipase (LipY) was overexpressed in Mycobacterium bovis BCG. Efficacy of recombinant BCG to protect against infection of M. tuberculosis was evaluated in
  • 2,3-dideoxy hex-2-enopyranosid-4-uloses as promising new anti-tubercular agents: design, synthesis, biological evaluation and SAR studies.

    Authors: Mohammad Saquib, Irfan Husain, Smriti Sharma, Garima Yadav, Vipul K Singh, Sandeep K Sharma, Priyanka Shah, Mohammad Imran Siddiqi, Brijesh Kumar, Jawahar Lal, Girish K Jain, Brahm S Srivastava, Ranjana Srivastava, Arun K Shaw

    European journal of medicinal chemistry. 03/2011; 46(6):2217-23.

    The alarming resurgence of tuberculosis (TB) underlines the urgent need for development of new and potent anti-TB drugs. Towards this goal we herein report the design and synthesis of 2,3-dideoxy
  • Downregulation of Rv0189c, encoding a dihydroxyacid dehydratase, affects growth of Mycobacterium tuberculosis in vitro and in mice.

    Authors: Vinayak Singh, Deepak Chandra, Brahm S Srivastava, Ranjana Srivastava

    Microbiology (Reading, England). 01/2011; 157(Pt 1):38-46.

    Dihydroxyacid dehydratase (DHAD), a key enzyme involved in branched-chain amino acid (BCAA) biosynthesis, catalyses the synthesis of 2-ketoacids from dihydroxyacids. In Mycobacterium tuberculosis,
  • Biochemical and transcription analysis of acetohydroxyacid synthase isoforms in Mycobacterium tuberculosis identifies these enzymes as potential targets for drug development.

    Authors: Vinayak Singh, Deepak Chandra, Brahm S Srivastava, Ranjana Srivastava

    Microbiology (Reading, England). 09/2010; 157(Pt 1):29-37.

    Acetohydroxyacid synthase (AHAS) is a biosynthetic enzyme essential for de novo synthesis of branched-chain amino acids. The genome sequence of Mycobacterium tuberculosis revealed genes encoding four
  • Comparative expression analysis of rpf-like genes of Mycobacterium tuberculosis H37Rv under different physiological stress and growth conditions.

    Authors: Ravi Kr Gupta, Brahm S Srivastava, Ranjana Srivastava

    Microbiology (Reading, England). 09/2010; 156(Pt 9):2714-22.

    Mycobacterium tuberculosis H37Rv possesses five resuscitation-promoting factors, RpfA-E, which are required for the resuscitation of dormancy in mycobacteria induced by prolonged incubation of the
  • Fast-growing, non-infectious and intracellularly surviving drug-resistant Mycobacterium aurum: a model for high-throughput antituberculosis drug screening.

    Authors: Antima Gupta, Sanjib Bhakta, Subir Kundu, Manish Gupta, Brahm S Srivastava, Ranjana Srivastava

    The Journal of antimicrobial chemotherapy. 09/2009;

    Objectives Enoyl acyl-carrier-protein reductase (InhA), the primary endogenous target for isoniazid and ethionamide, is crucial to type-II fatty acid biosynthesis (FAS-II). The objectives of this
  • Variable-number tandem repeat 3690 polymorphism in Indian clinical isolates of Mycobacterium tuberculosis and its influence on transcription.

    Authors: Parvez Akhtar, Sarman Singh, Pablo Bifani, Satinder Kaur, Brahm S Srivastava, Ranjana Srivastava

    Journal of medical microbiology. 07/2009; 58(Pt 6):798-805.

    Variable-number tandem repeat (VNTRs) occur throughout the chromosome of Mycobacterium tuberculosis. Although these polymorphic VNTRs, also known as mycobacterial interspersed repetitive units
  • Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.

    Authors: Juthika Kundu, Rupa Mazumder, Ranjana Srivastava, Brahm S Srivastava

    FEMS immunology and medical microbiology. 06/2009;

    Abstract Intranasal immunization, a noninvasive method of vaccination, has been found to be effective in inducing systemic and mucosal immune responses. The present study was aimed at investigating
  • A transposon insertion mutant of Mycobacterium fortuitum attenuated in virulence and persistence in a murine infection model that is complemented by Rv3291c of Mycobacterium tuberculosis.

    Authors: R P S Parti, Rahul Shrivastava, S Srivastava, A R Subramanian, Raja Roy, Brahm S Srivastava, Ranjana Srivastava

    Microbial pathogenesis. 10/2008;

    Mycobacterium fortuitum is a non-tubercular fast growing pathogenic mycobacteria whose virulence factors have not been studied. Infection of M. fortuitum ATCC 6841 in a murine infection model leads
  • Selection of genes of Mycobacterium tuberculosis upregulated during residence in lungs of infected mice.

    Authors: Vikas Srivastava, Anamika Jain, Brahm S Srivastava, Ranjana Srivastava

    Tuberculosis (Edinburgh, Scotland). 06/2008; 88(3):171-7.

    In sequel to previous report [Srivastava V, Rouanet C, Srivastava R, Ramalingam B, Locht C, Srivastava BS. Macrophage-specific Mycobacterium tuberculosis genes: identification by green fluorescent
  • Identification of genes of Mycobacterium tuberculosis upregulated during anaerobic persistence by fluorescence and kanamycin resistance selection.

    Authors: Alka Saxena, Vikas Srivastava, Ranjana Srivastava, Brahm S Srivastava

    Tuberculosis (Edinburgh, Scotland). 04/2008;

    Molecular mechanisms involved in maintaining the latent infection of Mycobacterium tuberculosis are least understood. We have applied principles of in vivo expression technology (IVET) to identify
  • C-3 alkyl/arylalkyl-2,3-dideoxy hex-2-enopyranosides as antitubercular agents: synthesis, biological evaluation, and QSAR study.

    Authors: Mohammad Saquib, Manish K Gupta, Ram Sagar, Yenamandra S Prabhakar, Arun K Shaw, Rishi Kumar, Prakas R Maulik, Anil N Gaikwad, Sudhir Sinha, Anil K Srivastava, Vinita Chaturvedi, Ranjana Srivastava, Brahm S Srivastava

    Journal of medicinal chemistry. 07/2007; 50(13):2942-50.

    A series of C-3 alkyl and arylalkyl 2,3-dideoxy hex-2-enopyranoside derivatives were synthesized by Morita-Baylis-Hillman reaction using enulosides 4, 5, and 6 and various aliphatic and aromatic
  • Macrophage-specific Mycobacterium tuberculosis genes: identification by green fluorescent protein and kanamycin resistance selection.

    Authors: Vikas Srivastava, Carine Rouanet, Ranjana Srivastava, B Ramalingam, Camille Locht, Brahm S Srivastava

    Microbiology (Reading, England). 04/2007; 153(Pt 3):659-66.

    Mycobacterium tuberculosis survives and multiplies inside macrophages of its host by modulating the expression of several genes essential for in vivo survival. An in vivo expression system has been
  • Identification of a repetitive sequence belonging to a PPE gene of Mycobacterium tuberculosis and its use in diagnosis of tuberculosis.

    Authors: Ranjana Srivastava, D Kumar, M N Waskar, Meera Sharma, V M Katoch, Brahm S Srivastava

    Journal of medical microbiology. 09/2006; 55(Pt 8):1071-7.

    A repetitive sequence specific to Mycobacterium tuberculosis was isolated from a lambda gt11 library of M. tuberculosis by DNA-DNA hybridization using genomic DNA of M. tuberculosis as probe followed
  • Vibrio cholerae persistence in aquatic environments and colonization of intestinal cells: involvement of a common adhesion mechanism.

    Authors: Massimiliano Zampini, Carla Pruzzo, Vijay P Bondre, Renato Tarsi, Mariangela Cosmo, Alessandro Bacciaglia, Arvind Chhabra, Renjana Srivastava, Brahm S Srivastava

    FEMS microbiology letters. 04/2005; 244(2):267-73.

    Forty-one Tnpho A mutants of Vibrio cholerae O1 classical strain CD81 were analyzed for their ability to interact with chitin particles, Tigriopus fulvus copepods and the Intestine 407 cell line
  • Diaryloxy methano phenanthrenes: a new class of antituberculosis agents.

    Authors: Gautam Panda, Shagufta, Jitendra Kumar Mishra, Vinita Chaturvedi, Anil K Srivastava, Ranjana Srivastava, Brahm S Srivastava

    Bioorganic & medicinal chemistry. 11/2004; 12(20):5269-76.

    A new series of diaryloxy methano phenanthrenes were prepared through tertiary-aminoalkylations of [(methoxy-phenyl)-phenanthren-9-yl-methyl]-phenols obtained from Friedel-Crafts alkylations on
  • Mutation in tcpR gene (Vc0832) of Vibrio cholerae O1 causes loss of tolerance to high osmolarity and affects colonization and virulence in infant mice.

    Authors: Arunima Mishra, Ranjana Srivastava, Carla Pruzzo, Brahm S Srivastava

    Journal of medical microbiology. 12/2003; 52(Pt 11):933-9.

    Vibrio cholerae, the agent of cholera, multiplies and colonizes human intestinal tract where it survives high osmolarity due to bile and other sodium salts. In this work, by TnphoA mutagenesis, a
  • Baylis-Hillman reaction: convenient ascending syntheses and biological evaluation of acyclic deoxy monosaccharides as potential antimycobacterial agents.

    Authors: Rashmi Pathak, Chandra Shekhar Pant, Arun K Shaw, Amiya P Bhaduri, Anil N Gaikwad, Sudhir Sinha, Anil Srivastava, Kishore K Srivastava, Vinita Chaturvedi, Ranjana Srivastava, Brahm S Srivastava

    Bioorganic & medicinal chemistry. 11/2002; 10(10):3187-96.

    A series of acyclic deoxy carbohydrate derivatives from easily available carbohydrate enals 1, 2, 3 or 5 were prepared involving the Baylis-Hillman reaction. These newly formed carbohydrate based

Are you Brahm S Srivastava?

Claim your profile

Keywords of Brahm S Srivastava

bovis BCG
 
fluorescent protein
 
green fluorescent protein
 
M. tuberculosis
 
M. tuberculosis H37Rv
 
murine infection model
 
Mycobacterium tuberculosis
 
tuberculosis H37Rv
 
wild type characteristics
 
wild type strain
 
65.48
Impact Points
24
Publications
1
Follower

Institutions

  • 2010–2011
    • Council of Scientific and Industrial Research (CSIR)
      New Delhi, NCT, India
  • 2002–2009
    • Central Drug Research Institute
      Lucknow, Uttar Pradesh, India
  • 2005
    • Università Politecnica delle Marche
      Ancona, The Marches, Italy